| A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis (NCT07692165) | Innatus Therapeutics (Shanghai) Co., Ltd. | 2026-06-11 |
| SG301-SC Injection Safety Study in Subjects With Primary ITP Patients (NCT07710248) | Hangzhou Sumgen Biotech Co., Ltd. | 2026-06-11 |
| A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS) (NCT07071935) | University of Pennsylvania | 2026-06-11 |
| A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM (NCT07608354) | AstraZeneca | 2026-06-11 |
| A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer (NCT07424664) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-06-11 |
| A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors (NCT07656727) | BioAge Labs, Inc. | 2026-06-11 |
| Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy (NCT07493395) | University Hospital, Montpellier | 2026-06-11 |
| A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia (NCT07646678) | Takeda | 2026-06-11 |
| Tirzepatide in MetALD (NCT07046819) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2026-06-11 |
| Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression (NCT07539805) | First Affiliated Hospital of Chongqing Medical University | 2026-06-11 |
| A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder (NCT07460947) | Mclean Hospital | 2026-06-10 |
| Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease (NCT07682896) | Yarrow Bioscience, Inc. | 2026-06-10 |
| Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases (NCT07043608) | Kelly Fitzgerald, MD | 2026-06-10 |
| Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients (NCT07560475) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-10 |
| Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery (NCT07013591) | Brigham and Women's Hospital | 2026-06-10 |
| Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer (NCT07605364) | Alliance for Clinical Trials in Oncology | 2026-06-10 |
| Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC (NCT07639138) | Shunda Du | 2026-06-10 |
| BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases (NCT07550088) | Darren Sigal, MD | 2026-06-10 |
| A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy (NCT07468851) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-06-10 |
| Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07682376) | Harbin Medical University | 2026-06-10 |
| Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma (NCT07222657) | Case Comprehensive Cancer Center | 2026-06-10 |
| Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency (NCT07551804) | Xiamen Amoytop Biotech Co., Ltd. | 2026-06-10 |
| Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear (NCT07219654) | Tego Science, Inc. | 2026-06-09 |
| A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment (NCT07179315) | University of Chicago | 2026-06-09 |
| Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma (NCT07624487) | Taipei Medical University Hospital | 2026-06-09 |
| Exogenous Ketone Supplementation in ICU Delirium (NCT07364162) | Vanderbilt University Medical Center | 2026-06-09 |
| A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity (NCT07639021) | Novo Nordisk A/S | 2026-06-09 |
| Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease (NCT07514338) | Pharming Technologies B.V. | 2026-06-09 |
| A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection (ABMR). (NCT07641426) | CASI pharmaceuticals, Inc. | 2026-06-09 |
| 18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer (NCT05982496) | Università Vita-Salute San Raffaele | 2026-06-09 |
| A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02) (NCT07554456) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-06-09 |
| Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL：Stop Trial 2.0 (NCT07682415) | Yi Shuhua | 2026-06-08 |
| Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease (NCT07252050) | Arkansas Children's Hospital Research Institute | 2026-06-08 |
| MRG003 With Gemcitabine for Second-line Advanced PDAC (NCT07685470) | Peking Union Medical College Hospital | 2026-06-08 |
| A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis (NCT07547436) | Sanofi | 2026-06-08 |
| Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments (NCT07468071) | Novartis Pharmaceuticals | 2026-06-08 |
| A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer (NCT07689656) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-06-08 |
| Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD (NCT07652294) | Spyre Therapeutics, Inc. | 2026-06-08 |
| Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia (NCT07657793) | Chinese SLE Treatment And Research Group | 2026-06-07 |
| Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer（Phase II） (NCT07673835) | Obstetrics & Gynecology Hospital of Fudan University | 2026-06-06 |
| A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy. (NCT07666555) | Fudan University | 2026-06-06 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer (NCT07560124) | Akeso | 2026-06-06 |
| A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer (NCT07661173) | Anhui Provincial Cancer Hospital | 2026-06-06 |
| AKK Study in Improving Obesity and Metabolic Status in Children and Adolescents (NCT07593170) | Central South University | 2026-06-06 |
| Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial (NCT07649174) | Obstetrics & Gynecology Hospital of Fudan University | 2026-06-06 |
| Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer (NCT07621562) | First Affiliated Hospital of Zhejiang University | 2026-06-05 |
| A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults (NCT07628049) | GlaxoSmithKline | 2026-06-05 |
| A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events (NCT07448038) | Genentech, Inc. | 2026-06-05 |
| Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma (NCT07639983) | Sheng Tai | 2026-06-05 |
| ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer (NCT06224673) | Laura Huppert, MD, BA | 2026-06-05 |
| Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis (NCT07734415) | Inmagene LLC | 2026-06-05 |
| Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma (NCT07321912) | Milton S. Hershey Medical Center | 2026-06-05 |
| Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game. (NCT07294131) | Vrije Universiteit Brussel | 2026-06-05 |
| Multi-Site Trial of Tirzepatide for Smoking Cessation (NCT07602699) | University of Southern California | 2026-06-05 |
| A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B (NCT07635186) | Ausper Biopharma Co., Ltd. | 2026-06-05 |
| hUC-MSC-Exosomes for T2DM - Safety & Efficacy (NCT07693036) | Peking University First Hospital | 2026-06-05 |
| Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study (NCT07511049) | National Institute of Neurological Disorders and Stroke (NINDS) | 2026-06-05 |
| Fructose for Acute Ischemic Stroke (NCT07626541) | Ji Xunming,MD,PhD | 2026-06-05 |
| Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors. (NCT07570563) | Chinese PLA General Hospital | 2026-06-05 |
| Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy (NCT07453095) | Fondazione Italiana Linfomi - ETS | 2026-06-05 |
| A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM) (NCT07428369) | Regeneron Pharmaceuticals | 2026-06-05 |
| Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab (NCT07486817) | Boehringer Ingelheim | 2026-06-04 |
| A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations (NCT07629960) | Blueprint Medicines Corporation | 2026-06-04 |
| An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer (NCT07589569) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-04 |
| A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement (NCT07359820) | Elevar Therapeutics | 2026-06-04 |
| Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence (NCT07521137) | Sano Chemicals Inc | 2026-06-04 |
| Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury (NCT07236463) | Centre Hospitalier Universitaire de Nīmes | 2026-06-04 |
| DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia (NCT07623525) | Diagonal Therapeutics, Inc. | 2026-06-04 |
| Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab (NCT07024706) | AstraZeneca | 2026-06-04 |
| A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy) (NCT07633301) | Takeda | 2026-06-04 |
| A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (NCT07544056) | BeBetter Med Inc | 2026-06-04 |
| UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF (NCT06860334) | Liverpool School of Tropical Medicine | 2026-06-04 |
| Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease (NCT07556718) | University of Michigan | 2026-06-03 |
| Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer (NCT07590934) | AstraZeneca | 2026-06-03 |
| An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis (NCT07620392) | Hoffmann-La Roche | 2026-06-03 |
| Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer (NCT07635290) | West China Hospital | 2026-06-03 |
| Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis (NCT07510607) | Ari Green | 2026-06-03 |
| Phentermine's Impact on Treatment in Teens (NCT07282340) | Russell McCulloh, MD | 2026-06-03 |
| EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC) (NCT07202000) | Massachusetts General Hospital | 2026-06-03 |
| A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis (NCT07489885) | InventisBio Co., Ltd | 2026-06-03 |
| aPBI Re-irradiation (NCT07612254) | Dartmouth-Hitchcock Medical Center | 2026-06-03 |
| Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration (NCT07630649) | Adverum Biotechnologies, Inc. | 2026-06-02 |
| A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy (NCT07668804) | Theratocular Biotek Co. | 2026-06-02 |
| Using Mobile Stress Management to Reduce Hypertension in African American Men (NCT07594808) | ISA Associates, Inc. | 2026-06-02 |
| Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC (NCT07018947) | Fundacion Clinic per a la Recerca Biomédica | 2026-06-02 |
| A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. (NCT07623642) | GV20 Therapeutics | 2026-06-02 |
| Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels (NCT07282912) | Yale University | 2026-06-02 |
| A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius) (NCT07646587) | Windward Bio | 2026-06-02 |
| Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. (NCT07394946) | Cancer Care Hospital & Research Centre Foundation, Lahore | 2026-06-01 |
| STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE (NCT07341022) | Hospital Israelita Albert Einstein | 2026-06-01 |
| Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger (NCT07569302) | Bedaya Hospital | 2026-06-01 |
| Immunity and Safety of Covid-19 Synthetic Minigene Vaccine (NCT04276896) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Electrophysiological Analysis of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients (NCT07596342) | Assistance Publique - Hôpitaux de Paris | 2026-06-01 |
| Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET (NCT07285993) | Randy Yeh | 2026-06-01 |
| Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC (NCT07353476) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Vertebrobasilar Dolichoectasia Treatment With Amiloride (NCT07634068) | Huashan Hospital | 2026-06-01 |
| Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke) (NCT07635758) | Chinese PLA General Hospital | 2026-06-01 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat (NCT07608770) | Caliway Biopharmaceuticals Co., Ltd. | 2026-06-01 |
| SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer (NCT07662811) | Shanghai Chest Hospital | 2026-06-01 |
| A Study in Adults With Geographic Atrophy (NCT07606365) | Sitala Bio LTD | 2026-06-01 |